Zhongyuan Union Cell & Gene Engineering (SHSE:600645) EBIT per Share : ¥0.25 (TTM As of Mar. 2025)

View and export this data going back to 1993. Start your Free Trial

What is Zhongyuan Union Cell & Gene Engineering EBIT per Share?

Zhongyuan Union Cell & Gene Engineering's EBIT per Share for the three months ended in Mar. 2025 was ¥0.08. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.25.

During the past 12 months, the average EBIT per Share Growth Rate of Zhongyuan Union Cell & Gene Engineering was -1.00% per year. During the past 3 years, the average EBIT per Share Growth Rate was 3.10% per year. During the past 5 years, the average EBIT per Share Growth Rate was 3.30% per year. During the past 10 years, the average EBIT per Share Growth Rate was 7.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Zhongyuan Union Cell & Gene Engineering's EBIT per Share or its related term are showing as below:

SHSE:600645' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -139.3 Med: 3.9 Max: 188.8
Current: 3.1

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Zhongyuan Union Cell & Gene Engineering was 188.80% per year. The lowest was -139.30% per year. And the median was 3.90% per year.

SHSE:600645's 3-Year EBIT Growth Rate is ranked worse than
55.83% of 1236 companies
in the Biotechnology industry
Industry Median: 8.1 vs SHSE:600645: 3.10

Zhongyuan Union Cell & Gene Engineering's EBIT for the three months ended in Mar. 2025 was ¥36 Mil.

Zhongyuan Union Cell & Gene Engineering EBIT per Share Historical Data

The historical data trend for Zhongyuan Union Cell & Gene Engineering's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhongyuan Union Cell & Gene Engineering EBIT per Share Chart

Zhongyuan Union Cell & Gene Engineering Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EBIT per Share

Get a 7-Day Free Trial

-0.18

0.48

0.33

0.29

0.30

Zhongyuan Union Cell & Gene Engineering Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EBIT per Share	Get a 7-Day Free Trial															0.13	0.12	0.14	-0.09	0.08

Zhongyuan Union Cell & Gene Engineering EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Zhongyuan Union Cell & Gene Engineering's EBIT per Share for the fiscal year that ended in Dec. 2024 is calculated as

	EBIT per Share		(A: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	136.538	/	456.146
=	0.30

Zhongyuan Union Cell & Gene Engineering's EBIT per Share for the quarter that ended in Mar. 2025 is calculated as

	EBIT per Share		(Q: Mar. 2025 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	36.275	/	467.174
=	0.08

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.25

Zhongyuan Union Cell & Gene Engineering (SHSE:600645) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Zhongyuan Union Cell & Gene Engineering EBIT per Share Related Terms

Thank you for viewing the detailed overview of Zhongyuan Union Cell & Gene Engineering's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhongyuan Union Cell & Gene Engineering Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhongyuan Union Cell & Gene Engineering Corp Ltd (SHSE:600645) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

45 East of Tianjin Airport Economic Zone nine, Tianjin, CHN, 300304

Website

http://www.vcanbio.com

Zhongyuan Union Cell & Gene Engineering Corp Ltd is engaged in stem cell technology research, as well as detection and storage sources of stem cells in China. The company insists on the core strategy upon dual-core development of 'cell + gene' with the major businesses covering various cell storage businesses of newborns and adults; the preparation and storage of cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental pluripotent stem cells, adipose-derived stem cells and immune cells; genetic testing services relating to children's genes.

Executives

Li De Fu	Director
Wang Xue Jun	senior management
Wang Yong	Director
Li Hai Bin	Director
He Wei	senior management
Li Qiang	senior management
Wu Ming Yuan	Director
Wang Hui	Director
Huang Jia Xue	senior management
Cao Hai Feng	Director
Han Yue E	Director
Liu Yong Jun	senior management
Cui Jing Xue	Supervisors
Yang Guang Xing	senior management
Meng Zhi Hong	senior management

Zhongyuan Union Cell & Gene Engineering Headlines

No Headlines